| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005592966 |
| P356 | DOI | 10.1007/S11906-010-0105-7 |
| P932 | PMC publication ID | 3093757 |
| P698 | PubMed publication ID | 20424953 |
| P5875 | ResearchGate publication ID | 43349090 |
| P2093 | author name string | Eric Lazartigues | |
| Huijing Xia | |||
| P2860 | cites work | A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 |
| A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 | ||
| Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation | Q24311938 | ||
| ACE2: a new target for cardiovascular disease therapeutics | Q24337633 | ||
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme | Q28216431 | ||
| ACE2 and diabetic complications | Q28250695 | ||
| Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function | Q28264715 | ||
| Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension | Q33639490 | ||
| Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure | Q33783409 | ||
| Genetic analysis of blood pressure in 8 mouse intercross populations | Q33789140 | ||
| Role of nitric oxide in the neural control of cardiovascular function | Q33847630 | ||
| Physiology of local renin-angiotensin systems. | Q34543927 | ||
| Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system | Q35567432 | ||
| Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system | Q36952795 | ||
| Brain renin angiotensin in disease | Q37127331 | ||
| Angiotensin-converting enzyme 2 in the brain: properties and future directions | Q37155907 | ||
| Genomic and proteomic approaches for targeting of angiotensin-converting enzyme2 for cardiovascular diseases | Q37180521 | ||
| Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice | Q37225431 | ||
| Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats | Q37247541 | ||
| Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease | Q37349063 | ||
| Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. | Q37352071 | ||
| Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 | ||
| Differential baroreceptor reflex modulation by centrally infused angiotensin peptides | Q42462109 | ||
| Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7). | Q43612370 | ||
| Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats | Q45069630 | ||
| Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase | Q45086400 | ||
| Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats | Q48107212 | ||
| Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats | Q48169169 | ||
| Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats | Q48260358 | ||
| Angiotensin II in central nervous system physiology | Q48311566 | ||
| Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus. | Q50511397 | ||
| Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. | Q53593286 | ||
| Interaction of bradykinin and angiotensin-(1–7) in the central modulation of the baroreflex control of the heart rate | Q62124895 | ||
| Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs | Q73457822 | ||
| Involvement of angiotensin-(1-7) in the hypothalamic hypotensive effect of captopril in sinoaortic denervated rats | Q81239804 | ||
| Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats | Q81419036 | ||
| Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis | Q83172375 | ||
| P433 | issue | 3 | |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 170-175 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | Angiotensin-converting enzyme 2: central regulator for cardiovascular function | |
| P478 | volume | 12 |
| Q90349742 | ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons |
| Q90046431 | Activation of ADAM17 (A Disintegrin and Metalloprotease 17) on Glutamatergic Neurons Selectively Promotes Sympathoexcitation |
| Q36152606 | An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia |
| Q38206728 | Angiotensin II and vascular injury |
| Q38207841 | Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets |
| Q37440125 | Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology |
| Q35550937 | Angiotensin-converting enzyme 2: the first decade |
| Q35776904 | Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension |
| Q98779021 | COVID-19 and Central Nervous System: Entry Routes And |
| Q98947021 | COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside |
| Q98627373 | COVID-19 and the central nervous system |
| Q35680217 | Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR |
| Q38781945 | Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension. |
| Q92710285 | Counter-regulatory renin-angiotensin system in cardiovascular disease |
| Q47845003 | Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice |
| Q48342917 | Determining the Enzymatic Activity of Angiotensin-Converting Enzyme 2 (ACE2) in Brain Tissue and Cerebrospinal Fluid Using a Quenched Fluorescent Substrate. |
| Q35776021 | Early Training-Induced Reduction of Angiotensinogen in Autonomic Areas-The Main Effect of Exercise on Brain Renin-Angiotensin System in Hypertensive Rats |
| Q94475377 | Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system |
| Q97088806 | Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus |
| Q36917960 | Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors. |
| Q98726051 | Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19 |
| Q41015495 | Many Faces of Renin-angiotensin System - Focus on Eye. |
| Q90724514 | Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19 |
| Q103826093 | Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories |
| Q33913160 | Overexpression of angiotensin-converting enzyme 2 attenuates tonically active glutamatergic input to the rostral ventrolateral medulla in hypertensive rats |
| Q38800189 | Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring |
| Q94466083 | Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19 |
| Q98176768 | Psychiatric face of COVID-19 |
| Q90011350 | Role of brain renin angiotensin system in neurodegeneration: An update |
| Q52352341 | Shear stress: An essential driver of endothelial progenitor cells. |
| Q99724031 | Syncope at SARS-CoV-2 onset |
| Q96647279 | The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review |
| Q58562702 | The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications |
Search more.